Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Aarti Drugs has informed that the Company has issued Duplicate share certificates in lieu of original share certificates, details of which are attached. The aforesaid Duplicate Share Certificates have been issued after compliance of required formalities in this regard.
The above information is a part of company’s filings submitted to BSE.
